V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270008123 | 270012478 | null | 79.8 | Curative (C) | 2017-09-25 | 2017-09-25 | HD EuroNet-PHL-C1 OEPA | N | null | 270015902 | OEPA |
| 270008124 | 270015838 | 1.77 | 99 | Not known (9) | 2016-06-15 | 2016-06-23 | Capecitabine 35days + RT | 02 | N | 270015904 | CAPECITABINE + RT |
| 270008125 | 270015838 | null | 57.8 | Curative (C) | 2013-07-26 | 2013-07-28 | HD EuroNet-PHL-C1 OEPA | N | N | 270015904 | OEPA |
| 270008126 | 270015838 | 1.8 | 20.8 | Palliative (P) | null | 2014-11-06 | Irinotecan + Modified De Gramont | 2 | N | 270015904 | IRINOTECAN + MDG |
| 270008127 | 270015838 | 1.6 | 40.9 | Neo-adjuvant (N) | null | 2015-12-13 | CAPECITABINE + RT | 02 | Y | 270015904 | CAPECITABINE + RT |
| 270008128 | 270015838 | 1.6 | 59.1 | Neo-adjuvant (N) | null | 2016-04-09 | CAPECITABINE + RT | N | null | 270015904 | CAPECITABINE + RT |
| 270008129 | 270015838 | 1.61 | 103.5 | Curative (C) | 2014-03-10 | 2014-03-25 | OEPA | 2 | null | 270015904 | OEPA |
| 270008130 | 270004932 | 1.58 | 26 | Palliative (P) | 2014-02-09 | 2014-03-07 | Irinotecan + Modified De Gramont | N | N | 270015912 | IRINOTECAN + MDG |
| 270008131 | 270012479 | 1.69 | 82.55 | null | 2017-04-29 | 2017-05-08 | CHLVPP | 02 | null | 270015913 | CHLVPP |
| 270008132 | 270012479 | 1.05 | 54.7 | Adjuvant (A) | 2013-01-21 | 2013-02-07 | HD EuroNet-PHL-C1 OEPA | 01 | N | 270015913 | OEPA |
| 270008133 | 270004933 | 1.32 | 98 | Neo-adjuvant (N) | null | 2017-01-05 | Capecitabine 42days + RT | N | Y | 270015916 | CAPECITABINE + RT |
| 270008134 | 270004934 | 1.54 | 69.6 | Neo-adjuvant (N) | 2017-11-23 | 2017-11-25 | Irinotecan + Modified De Gramont | N | N | 270015918 | IRINOTECAN + MDG |
| 270008135 | 270004935 | null | 95.5 | Curative (C) | null | 2017-03-09 | HD EuroNet-PHL-C1 OEPA | N | N | 270015919 | OEPA |
| 270008136 | 270004935 | 0 | 51.1 | Curative (C) | 2013-09-14 | 2013-09-21 | OEPA | N | N | 270015919 | OEPA |
| 270008137 | 270004936 | 1.5 | 28.6 | Curative (C) | 2017-01-24 | 2017-01-26 | CHLVPP | 02 | N | 270015921 | CHLVPP |
| 270008138 | 270004937 | 1.91 | 97.3 | Palliative (P) | null | 2013-02-19 | Irinotecan + Modified De Gramont | 02 | N | 270015923 | IRINOTECAN + MDG |
| 270008139 | 270004937 | null | 59.2 | Curative (C) | 2017-09-08 | 2017-09-18 | CHLVPP | N | null | 270015923 | CHLVPP |
| 270008140 | 270004937 | 1.67 | 77.2 | Neo-adjuvant (N) | 2013-10-24 | 2013-11-21 | CAPECITABINE + RT | 02 | Y | 270015923 | CAPECITABINE + RT |
| 270008141 | 270004937 | 1.64 | 77.95 | Not known (9) | 2016-04-20 | 2016-05-05 | CAPECITABINE + RT | N | null | 270015923 | CAPECITABINE + RT |
| 270008142 | 270004938 | 1.6 | null | Neo-adjuvant (N) | 2017-02-27 | 2017-03-22 | Capecitabine 35days + RT | N | Y | 270015929 | CAPECITABINE + RT |
| 270008143 | 270004939 | 0 | 53.7 | Adjuvant (A) | 2017-02-28 | 2017-03-16 | OEPA | N | N | 270015930 | OEPA |
| 270008144 | 270004940 | 1.66 | 75.1 | Neo-adjuvant (N) | 2015-10-09 | 2015-10-21 | CAPECITABINE + RT | 02 | Y | 270015933 | CAPECITABINE + RT |
| 270008145 | 270012482 | 1.6 | 78.9 | Palliative (P) | 2017-06-27 | 2017-07-02 | Irinotecan + Modified De Gramont | null | null | 270015934 | IRINOTECAN + MDG |
| 270008146 | 270012482 | 1.7 | 65 | Curative (C) | 2017-09-25 | 2017-10-19 | CAPECITABINE + RT | null | Y | 270015934 | CAPECITABINE + RT |
| 270008147 | 270012482 | 0 | 46 | Curative (C) | 2014-06-16 | 2014-06-24 | HD EuroNet-PHL-C1 OEPA | null | N | 270015934 | OEPA |
| 270008148 | 270004941 | 1.77 | 98 | Curative (C) | 2017-01-19 | 2017-02-02 | HD EuroNet-PHL-C1 OEPA | N | N | 270015939 | OEPA |
| 270008149 | 270004941 | 1.83 | 80.4 | Neo-adjuvant (N) | 2016-12-15 | 2017-01-12 | Capecitabine 35days + RT | 02 | null | 270015939 | CAPECITABINE + RT |
| 270008150 | 270004942 | null | 75.8 | Palliative (P) | 2014-12-10 | 2014-12-12 | CHLVPP | N | N | 270015942 | CHLVPP |
| 270008151 | 270004942 | 1.76 | 59.9 | Curative (C) | 2014-10-27 | 2014-11-01 | CHLVPP | N | N | 270015942 | CHLVPP |
| 270008152 | 270004942 | 1.79 | 83.2 | Neo-adjuvant (N) | 2016-01-05 | 2016-01-24 | Capecitabine 35days + RT | N | N | 270015942 | CAPECITABINE + RT |
| 270008153 | 270004942 | 1.7 | null | Curative (C) | 2015-01-28 | 2015-01-29 | CHLVPP | 02 | Y | 270015942 | CHLVPP |
| 270008154 | 270004943 | 1.76 | 67 | Adjuvant (A) | 2017-05-07 | 2017-05-24 | CHLVPP | N | N | 270015946 | CHLVPP |
| 270008155 | 270004943 | null | 59.7 | Palliative (P) | 2013-09-19 | 2013-10-10 | CISPLATIN + FLUOROURACIL | Y | N | 270015946 | CISPLATIN + FLUOROURACIL |
| 270008156 | 270004943 | 1.68 | 84.2 | Curative (C) | 2015-01-27 | 2015-02-07 | Escalated BEACOPP | N | N | 270015946 | BEACOPP |
| 270008157 | 270004943 | 1.78 | 119.2 | Adjuvant (A) | 2016-07-18 | 2016-08-15 | Cisplatin | 01 | N | 270015946 | CISPLATIN |
| 270008158 | 270018834 | 1.7 | 69.6 | Curative (C) | 2017-08-18 | 2017-08-22 | Escalated BEACOPP | 02 | N | 270015951 | BEACOPP |
| 270008159 | 270018834 | 1.65 | 63 | Adjuvant (A) | 2014-07-16 | 2014-07-16 | FLUOROURACIL | 02 | N | 270015951 | FLUOROURACIL |
| 270008160 | 270004944 | 1.79 | 87.5 | Palliative (P) | 2013-06-06 | 2013-08-15 | Trial Unspecified | N | N | 270015953 | TRIAL |
| 270008161 | 270004945 | 1.64 | 111.3 | Curative (C) | 2014-04-20 | 2014-05-04 | Cisplatin | 02 | Y | 270015954 | CISPLATIN |
| 270008162 | 270004945 | 1.75 | 53.4 | null | null | 2014-11-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 270015954 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270008163 | 270015844 | 1.99 | 72.5 | Curative (C) | 2014-05-16 | 2014-06-11 | Cisplatin | 02 | Y | 270015959 | CISPLATIN |
| 270008164 | 270004946 | 1.78 | 55.2 | Curative (C) | 2014-10-08 | 2014-10-09 | Escalated BEACOPP | N | N | 270015961 | BEACOPP |
| 270008165 | 270004947 | 1.52 | 84 | Neo-adjuvant (N) | 2017-12-17 | 2017-12-26 | Cisplatin +Fluorouracil (3 wk) | N | null | 270015962 | CISPLATIN + FLUOROURACIL |
| 270008166 | 270004948 | 1.68 | null | null | 2016-09-05 | 2016-09-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 270015963 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270008167 | 270004949 | null | 71.7 | Neo-adjuvant (N) | 2015-09-06 | 2015-09-12 | CISPLATIN + FLUOROURACIL | N | N | 270015965 | CISPLATIN + FLUOROURACIL |
| 270008168 | 270012487 | 1.71 | null | Curative (C) | 2017-09-01 | 2017-09-22 | Escalated BEACOPP | N | N | 270015967 | BEACOPP |
| 270008169 | 270004950 | 1.73 | 47 | Curative (C) | 2013-09-03 | 2013-09-03 | HD EuroNet-PHL-C1 COPDAC | N | N | 270015970 | TRIAL |
| 270008170 | 270004950 | 1.65 | 87 | null | 2014-08-03 | 2014-08-26 | Cisplatin 7 day | 1 | Y | 270015970 | CISPLATIN |
| 270008171 | 270004951 | 1.81 | 79.45 | Palliative (P) | 2016-09-19 | 2016-09-19 | CHOP R | N | N | 270015974 | CHOP R |
| 270008172 | 270004951 | 1.75 | 67 | Palliative (P) | 2013-08-22 | 2013-09-10 | Fluorouricil + Folonic Acid (MdG) | N | N | 270015974 | FLUOROURACIL |